PAMP
JSPRW icon

Polar Asset Management Partners’s Japer Therapeutics Warrants JSPRW Stock Holding History

Polar Asset Management Partners’s Portfolio JSPRW Stock Details JSPRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-162,500
Closed -$236K – 1035
2020
Q4 		$236K Hold
162,500
– – ﹤0.01% 716
2020
Q3 		$192K Hold
162,500
– – ﹤0.01% 550
2020
Q2 		$162K Hold
162,500
– – ﹤0.01% 452
2020
Q1 		$106K Buy
+162,500
New +$128K ﹤0.01% 381

Other funds holding JSPRW

OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
SRCM
Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.48% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM

Polar Asset Management Partners's JSPRW Position: Q1 2021 in Review

Polar Asset Management Partners sold out of Japer Therapeutics Warrants (JSPRW) in Q1 2021, closing a stake of 162,500 shares — an estimated $236K sold.

Polar Asset Management Partners first reported a position in JSPRW in Q1 2020 and held it in 4 quarters. The position peaked at $236K in Q4 2020. 26 funds tracked by Wall St. Rank hold JSPRW as of Q1 2021.

  • Polar Asset Management Partners reported no remaining Japer Therapeutics Warrants position as of Q1 2021 after selling out during the quarter.
  • Polar Asset Management Partners sold 162,500 Japer Therapeutics Warrants shares in Q1 2021, an estimated $236K.
  • Polar Asset Management Partners first reported a position in Japer Therapeutics Warrants in Q1 2020 and held it in 4 quarters.
  • Polar Asset Management Partners's Japer Therapeutics Warrants position peaked at $236K in Q4 2020.
  • 26 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q1 2021.

Based on Polar Asset Management Partners's 13F filing for Q1 2021, filed 17 May 2021.